MDA-MB-468
 

Rincon Bio performs MDA-MB-468 xenograft models to test efficacy of preclinical therapies.  Please see below for additional information or to request a quote. 

Breast

MDA-MB-468 cells were isolated from a 51 year old female with adenocarcinoma of the breast

Oncogene

Although the tissue donor was heterozygous for the G6PD alleles, the cell line consistently showed only the G6PD A phenotype. There is a G -> A mutation in codon 273 of the p53 gene resulting in an Arg -> His substitution. EGF receptor is present at 1 X 106 per cell.  Ref

in vivo

Forms tumors in mice

Used in xenografts to test the efficacy of anti-cancer therapeutics

Request Quote

Receive a quote within one business day

Rincon Bio Growth Curve

MDA-MB-468.jpg

MDA-MB-468 cells implanted in NSG mice

WHY WORK WITH

RINCON BIO?

DOMESTIC QUALITY at COMPETITIVE PRICES

 

When you work with Rincon Bio, rest assured that all cancer efficacy studies will be performed in the USA, at competitive prices

SPEED TO INITIATION
 

Most efficacy studies can be initiated within two business days.

PERSONAL TOUCH

 

We love our clients!  We are easy to work with.  And we take a personal interest in our clients and their studies.